What are the recommended dosing regimens, safety monitoring, and clinical trial considerations for senolytic agents such as dasatinib + quercetin, navitoclax, fisetin, and FOXO4‑DRI? US$ 24.17 Min. order: 1 piece ★★★★★ 4.1 (190 reviews) Sold : Login>>
The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety US$ 24.97 Min. order: 1 piece ★★★★★ 4.6 (62 reviews) Sold : Login>>
Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis US$ 20.73 Min. order: 1 piece ★★★★★ 4.4 (92 reviews) Sold : Login>>
FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice US$ 20.14 Min. order: 1 piece ★★★★★ 4.7 (297 reviews) Sold : Login>>